Rauno A. Naves
Helsinki, Finland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Nucleocapsid protein enhances spike- and RBD-specific humoral and cellular immune responses in protein-based SARS-CoV-2 vaccine.
Journal: BMC infectious diseases
Published: November 21, 2025
Long-term COVID-19 vaccine- and Omicron infection-induced humoral and cell-mediated immunity.
Journal: Frontiers in immunology
Published: September 10, 2024
Intranasal trimeric sherpabody inhibits SARS-CoV-2 including recent immunoevasive Omicron subvariants.
Journal: Nature communications
Published: December 22, 2022
Coronavirus spike protein-specific antibodies indicate frequent infections and reinfections in infancy and among BNT162b2-vaccinated healthcare workers.
Journal: Scientific reports
Published: November 21, 2022
Comparative analysis of COVID-19 vaccine responses and third booster dose-induced neutralizing antibodies against Delta and Omicron variants.
Journal: Nature communications
Published: December 23, 2021
COVID-19 mRNA vaccine induced antibody responses against three SARS-CoV-2 variants.
Journal: Nature communications
Published: March 18, 2021
A Combination of N and S Antigens With IgA and IgG Measurement Strengthens the Accuracy of SARS-CoV-2 Serodiagnostics.
Journal: The Journal of infectious diseases
Published: January 09, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026